Lv4
580 积分 2022-09-19 加入
Pathophysiology and inhibition of cholesteryl ester transfer protein for prevention of cardiovascular diseases: An update
4个月前
已完结
Present therapeutic role of cholesteryl ester transfer protein inhibitors
4个月前
已完结
Controlled study of the effect of proprotein convertase subtilisin-kexin type 9 inhibition with evolocumab on lipoprotein(a) particle kinetics
4个月前
已完结
Mechanisms of unusual response to lipid-lowering therapy: PCSK9 inhibition
4个月前
已完结
Oral Muvalaplin for Lowering of Lipoprotein(a)
4个月前
已关闭
Oral Muvalaplin for Lowering of Lipoprotein(a)
4个月前
已完结
Oral Muvalaplin for Lowering of Lipoprotein(a)
4个月前
已完结
†Synergistic Effect of Obicetrapib and Ezetimibe on Circulating LDL Particles
4个月前
已完结
293-OR: Macrophage-Derived Interleukin-12 Regulates Obesity-Mediated Insulin Resistance in the Liver
5个月前
已关闭
The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis
5个月前
已关闭
皖公网安备34019202002308
